Contrast decision for Schering

Published: 28-May-2001


Schering's liver-specific MRI contrast agent Resovist has been approved in Sweden. It is injected as an iv bolus, and allows immediate imaging of the liver, reducing the overall examination time.

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.

You may also like